- AU$111.90m
- AU$2.12bn
- AU$143.46m
- 37
- 86
- 89
- 79
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 28.9 | 41.5 | 53.1 | 88.5 | 143 |
Cost of Revenue | |||||
Gross Profit | 27.9 | 39.9 | 50.4 | 77.6 | 125 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 42.1 | 57.7 | 68.2 | 99.2 | 158 |
Operating Profit | -13.3 | -16.2 | -15.1 | -10.7 | -14.6 |
Net Income Before Taxes | -13.3 | -16.2 | -15.1 | -10.7 | -14.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -13.3 | -16.2 | -15.1 | -6.32 | -13.6 |
Net Income Before Extraordinary Items | |||||
Net Income | -13.3 | -16.2 | -15.1 | -6.32 | -13.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -13.3 | -16.2 | -15.1 | -6.32 | -13.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.079 | -0.096 | -0.081 | -0.033 | -0.08 |
Dividends per Share |